FR1829M - New drug, in particular for the treatment of blood coagulability disorders. - Google Patents

New drug, in particular for the treatment of blood coagulability disorders.

Info

Publication number
FR1829M
FR1829M FR872595A FR872595A FR1829M FR 1829 M FR1829 M FR 1829M FR 872595 A FR872595 A FR 872595A FR 872595 A FR872595 A FR 872595A FR 1829 M FR1829 M FR 1829M
Authority
FR
France
Prior art keywords
disorders
treatment
new drug
blood coagulability
coagulability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR872595A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR872595A priority Critical patent/FR1829M/en
Priority to SE08904/62A priority patent/SE326292B/xx
Priority to CH980362A priority patent/CH415585A/en
Priority to DK369062AA priority patent/DK105155C/en
Priority to GB33602/62A priority patent/GB964223A/en
Application granted granted Critical
Publication of FR1829M publication Critical patent/FR1829M/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR872595A 1961-09-07 1961-09-07 New drug, in particular for the treatment of blood coagulability disorders. Active FR1829M (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR872595A FR1829M (en) 1961-09-07 1961-09-07 New drug, in particular for the treatment of blood coagulability disorders.
SE08904/62A SE326292B (en) 1961-09-07 1962-08-15
CH980362A CH415585A (en) 1961-09-07 1962-08-16 Process for preparing a new heparid compound
DK369062AA DK105155C (en) 1961-09-07 1962-08-23 Process for the preparation of the sodium slate of 3,5-disulfaminobenzheparide.
GB33602/62A GB964223A (en) 1961-09-07 1962-08-31 New derivatives of heparin,processes for their production,and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR872595A FR1829M (en) 1961-09-07 1961-09-07 New drug, in particular for the treatment of blood coagulability disorders.

Publications (1)

Publication Number Publication Date
FR1829M true FR1829M (en) 1963-05-27

Family

ID=8762436

Family Applications (1)

Application Number Title Priority Date Filing Date
FR872595A Active FR1829M (en) 1961-09-07 1961-09-07 New drug, in particular for the treatment of blood coagulability disorders.

Country Status (5)

Country Link
CH (1) CH415585A (en)
DK (1) DK105155C (en)
FR (1) FR1829M (en)
GB (1) GB964223A (en)
SE (1) SE326292B (en)

Also Published As

Publication number Publication date
SE326292B (en) 1970-07-20
DK105155C (en) 1966-08-29
GB964223A (en) 1964-07-22
CH415585A (en) 1966-06-30

Similar Documents

Publication Publication Date Title
FR2427M (en) Bacteriotherapeutic drug, in particular for the treatment of gastrointestinal disorders.
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR2739M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR1829M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR2683M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR1436M (en) New drug, in particular for the treatment of disorders of blood coagulability and plasma clarification.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR3269M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2913M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1690M (en) New drug in particular for the treatment of respiratory disorders, bronchitis, pneumonia and heart collapse and failure.
FR2323M (en) New drug, in particular for the treatment of follicle-stimulating hyperactivity.
FR1547M (en) New drug, in particular for the treatment of hypophyseal follicle stimulating hyperactivity.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR3479M (en) Ajmaline camphosulfonate, a new drug which can be used in particular for the treatment of certain cardiovascular disorders.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR35M (en) New drug, in particular for the treatment of hypophyseal follicle stimulating hyperactivity.
FR2786M (en) Drug for the treatment of heart disease.